The Australian market is showing mixed signals, with the ASX200 recently reaching record highs amidst fluctuating global indices and commodity prices. In such a climate, investors often look to penny stocks as a way to explore growth opportunities at lower price points. Although the term "penny stock" may seem outdated, these smaller or newer companies can still offer significant potential when backed by strong financials and clear growth prospects.

Top 10 Penny Stocks In Australia

Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.39 A$111.77M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.16 A$101.89M ★★★★★★ GTN (ASX:GTN) A$0.585 A$111.54M ★★★★★★ IVE Group (ASX:IGL) A$2.91 A$448.67M ★★★★★☆ West African Resources (ASX:WAF) A$2.39 A$2.72B ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.765 A$466.68M ★★★★★★ Regal Partners (ASX:RPL) A$3.00 A$1.01B ★★★★★★ Sugar Terminals (NSX:SUG) A$0.99 A$360M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$3.96 A$187.9M ★★★★★★ CTI Logistics (ASX:CLX) A$1.86 A$149.81M ★★★★☆☆

Click here to see the full list of 461 stocks from our ASX Penny Stocks screener.

Here's a peek at a few of the choices from the screener.

Clover

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Clover Corporation Limited specializes in the production, refining, and sale of natural oils and encapsulated powders across various regions including Australia, New Zealand, Asia, Europe, the Middle East, and the Americas with a market cap of A$98.53 million.

Operations: The company's revenue is primarily derived from its Nutritional Oil and Microencapsulated Powders segment, which generated A$72.49 million.

Market Cap: A$98.53M

Clover Corporation Limited, with a market cap of A$98.53 million, shows financial stability with short-term assets (A$53.9M) exceeding both short-term (A$9.3M) and long-term liabilities (A$4.2M). Its debt is well covered by operating cash flow, and interest payments are comfortably managed by EBIT. Despite a decline in earnings over the past five years, recent performance indicates significant recovery with a 135.4% earnings growth last year, surpassing industry averages. The company's Return on Equity remains low at 6.7%, but its experienced board and management team provide strategic oversight amidst stable weekly volatility levels of 9%.

Navigate through the intricacies of Clover with our comprehensive balance sheet health report here. Examine Clover's earnings growth report to understand how analysts expect it to perform.ASX:CLV Revenue & Expenses Breakdown as at Jul 2025

Omni Bridgeway

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Omni Bridgeway Limited, with a market cap of A$398.04 million, provides dispute and litigation finance services across various regions including Australia, the United States, Canada, Latin America, Asia, New Zealand, Europe, the Middle East, and Africa.

Story Continues

Operations: The company generates revenue of A$132.66 million from funding and providing services related to legal dispute resolution.

Market Cap: A$398.04M

Omni Bridgeway Limited, with a market cap of A$398.04 million, maintains financial resilience despite being unprofitable. Its short-term assets (A$915.8M) surpass both short-term (A$232.2M) and long-term liabilities (A$325.6M), ensuring liquidity and stability in operations. The company has a satisfactory net debt to equity ratio of 6.1%, indicating prudent financial management, although its debt to equity ratio has increased over five years from 18.8% to 30.2%. Despite not generating profits currently, Omni Bridgeway forecasts earnings growth at 28.27% annually and holds sufficient cash runway for more than three years if free cash flow remains positive.

Click here and access our complete financial health analysis report to understand the dynamics of Omni Bridgeway. Review our growth performance report to gain insights into Omni Bridgeway's future.ASX:OBL Financial Position Analysis as at Jul 2025

PointsBet Holdings

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: PointsBet Holdings Limited operates a cloud-based platform offering sports, racing, and iGaming betting products and services in Australia with a market cap of A$421.05 million.

Operations: The company's revenue is derived from its operations in Canada, generating A$36.24 million, and Australia, contributing A$216.01 million.

Market Cap: A$421.05M

PointsBet Holdings Limited, with a market cap of A$421.05 million, operates without debt but remains unprofitable despite reducing losses by 27.1% annually over the past five years. The company's revenue streams from Canada (A$36.24 million) and Australia (A$216.01 million) highlight its operational reach, yet short-term liabilities (A$62.3M) exceed short-term assets (A$39.2M), indicating potential liquidity challenges. Trading at 40.3% below estimated fair value presents an opportunity for value investors, while earnings are forecast to grow significantly at 112.8% per year, though current investor activism may introduce some uncertainty in the near term.

Take a closer look at PointsBet Holdings' potential here in our financial health report. Explore PointsBet Holdings' analyst forecasts in our growth report.ASX:PBH Debt to Equity History and Analysis as at Jul 2025

Taking Advantage

Unlock more gems! Our  ASX Penny Stocks screener has unearthed 458 more companies for you to explore.Click here to unveil our expertly curated list of 461  ASX Penny Stocks. Curious About Other Options? We've found 19 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:CLV ASX:OBL and ASX:PBH.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments